Informations générales (source: ClinicalTrials.gov)
Study of Mindfulness Practice Efficacy in Alcoholic Relapse Prevention (Mindfulness)
Interventional
N/A
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
janvier 2017
septembre 2018
29 juin 2024
Among behavioral cognitive psychotherapies, new "Mindfulness" interventions allow patient
to identify, pay attention and accept external (sensory stimuli) and internal (cognition
and emotions) phenomena. This "to do with" training has yielded promising results in
stress management, prevention of depressive relapse, management of craving and an
increase in self-efficacy. Few studies (none in France) have attempted to measure the
efficacy of this technique on alcohol relapse, in particular by comparing it with a usual
management strategy (conventional relapse prevention therapy).
The main objective of this study is to compare the efficacy on alcoholic relapse
(measured in the "first glass" consumed), from a Mindfulness therapeutic program to a
conventional Relapse Prevention program. Secondary objectives are to demonstrate the
efficacy of this program on craving, self-efficacy, and secondary endpoints of relapse
(massive alcoholism, number of alcoholisation days).
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CHU Clermont-Ferrand - 63003 - France - France | Patrick LACARIN | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Male or female aged 18 to 75 (including landmarks)
- Patients in withdrawal for alcohol dependence according to DSM IV criteria (1994);
hospital or outpatient withdrawal of more than 10 days and less than 10 weeks.
- Male or female aged 18 to 75 (including landmarks)
- Patients in withdrawal for alcohol dependence according to DSM IV criteria (1994);
hospital or outpatient withdrawal of more than 10 days and less than 10 weeks.
- Psychiatric comorbidity (dipsomaniac alcoholism, anteriority of one or more
hypomanic or manic episodes, psychoses, severe depression, severe suicidal risk)
- Other addiction syndrome than tobacco and alcohol
- Problems that impede participation in a group, such as severe borderline personality
disorder; antisocial personality; tendency to dissociation; phobias of interceptive
type (panic attacks and hypochondria ...)
- Problems preventing the completion of questionnaires, such as cognitive
dysfunctions, dysfunctions of attention and concentration skills, or a language
barrier
- Severe recurring pathology
- Need for individual weekly follow-up